Current Pharmacogenomics and Personalized Medicine (CPPM) is an interdisciplinary peer-reviewed biomedical journal that reports new findings and emerging concepts in both pharmacogenomics and personalized medicine under a single cover. CPPM is the official journal of the Pacific Rim Association for Clinical Pharmacogenetics and welcomes peer reviewed contributions from authors in any global region including the Asia-Pacific.

The Journal scope is defined by three inter-connected aims. First, we are interested in genomics/postgenomics biotechnologies and diagnostics that enable personalized medicine (including and beyond pharmacogenomics) as long as they explain person-to-person and population differences in disease susceptibility or response to a health intervention, and they can be mechanistically substantiated. Second, we approach personalized medicine as ‘personalized health interventions’ focusing primarily on drug therapy, but also other interventions such as nutrition, vaccines, surgical devices, emerging cell-based therapies that collectively contribute to healthcare. Third, we strive to integrate molecular and clinical investigation with social, ethical, public policy and global health impacts that together shape the innovation trajectories in pharmacogenomics and personalized medicine.

Priority will be given to expert reviews that include original ideas and concepts related to the Journal scope. Research articles will be considered for peer reviewed publication provided that they report a novel finding that informs the field of pharmacogenomics and personalized medicine.

This journal follows the International Committee of Medical Journal Editors (http://www.icmje.org) guidance for authorship, peer review and editorial independence. All manuscripts submitted for publication will be immediately subjected to editorial scrutiny. Manuscripts that do not conform to the CPPM format and editorial style will be returned to the authors. Only those articles that may potentially pass the rigorous standards of the peer review process are sent out for critical appraisal by independent expert referees invited from the international editorial board and the broader scientific community.

The CPPM offers an integrated multidisciplinary peer-reviewed forum for academic researchers, health professionals, pharmaceutical and biotechnology industries, policy makers, government and global public health stakeholders interested in genomics/postgenomics innovations in the field of personalized medicine. The journal is published four times per year and printed on acid-free paper.